A clinical trial involving leptin was registered on September 4, 2026. The study, titled "Effects of Different Exercise Types on Irisin, Leptin, and Ghrelin Levels in Sedentary Women," is listed under identifier NCT07805772.
The trial's current status is not yet recruiting, and it is listed as phase NA, indicating it is not part of the standard drug-phase classification system. The study aims to examine how different types of exercise relate to levels of irisin, leptin, and ghrelin in a population of sedentary women.
No results have been posted for this trial, and none should be inferred at this stage. The listing reflects only the trial's registration and planned design as of the date noted. Further updates would be expected as recruitment status changes or as data becomes available.
Readers interested in leptin can consult the compound overview for additional background and context.